We studied β-adrenergic and muscarinic cholinergic receptor (MR) expression and proliferative response in lymphocytes from animals under chronic mild stress (CMS) model of depression (CMS animals). Animals were subjected to CMS (periods of food or water deprivation, changes in lighting conditions, tilted cage, etc.) for 12 weeks. CMS lymphocytes showed an altered mitogen-induced proliferation. CMS-B and -T lymphocytes showed an increment on β-adrenoceptor number and on intracellular responses to a β-agonist. CMS-T cells showed higher MR expression and lower cGMP responses than normal lymphocytes. MR were not detectable in normal B cells while CMS-B cells showed both MR expression and cGMP response. Beta and muscarinic stimulation influenced lymphocyte proliferative responses, in accordance with cAMP and cGMP responses. After 12 weeks of the CMS procedure, animals were treated with fluoxetine while the CMS procedure continued. Fluoxetine treatment reverted the alterations induced by CMS. These findings suggest a possible mechanism for the immune alterations found in depressive disorders and for the effect of fluoxetine treatment on immune response.
Over the past several years, many studies have suggested an association between depression and immunological dysfunction (Irwin, 1995; Ravindran, Griffiths, Merali, & Anisman, 1998) . In general, major depressive disorder has been associated with a suppression of various aspects of immune response, such as a reduction of lymphocyte proliferation in response to mitogens (Hebert & Cohen, 1993) as well as reduced natural killer activity (Maes, 1995) . Attention has begun to focus on the possible biochemical and physiological mechanisms by which immune changes may be mediated (Irwin, 1995) . The most important mechanism involved has been the activation of both the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system. It has been extensively demonstrated that the sympathetic nervous system modulates the immune response via specific receptors localized in lymphoid organs or in circulating lymphoid cells (Felten, Felten, Bellinger, & Olschowka, 1992) . The existence of cholinergic innervation in lymphoid organs has not been proved yet but the presence of cholinergic receptors in lymphocytes has been demonstrated by binding and functional studies (Genaro, Cremaschi, & Borda, 1993; Malinski, Kullberg, Nordstrom, & Bartfai, 1988) .
Depressive disorders are very common in humans and are believed to be influenced and/or induced by a wide variety of factors, including genetic, biological, and environmental. Among the most potent environmental factors that may trigger or induce
